(Q43567698)

English

An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 study

scientific article published in May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 study (English)

1 reference

Europe PubMed Central

24 November 2017

gastroesophageal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Jaffer A Ajani

1 reference

Europe PubMed Central

24 November 2017

author name string

J Randolph Hecht

2

1 reference

Europe PubMed Central

24 November 2017

Linus Ho

3

1 reference

Europe PubMed Central

24 November 2017

Jackie Baker

4

1 reference

Europe PubMed Central

24 November 2017

Marga Oortgiesen

5

1 reference

Europe PubMed Central

24 November 2017

Arnavaz Eduljee

6

1 reference

Europe PubMed Central

24 November 2017

Dov Michaeli

7

1 reference

Europe PubMed Central

24 November 2017

language of work or name

0 references

publication date

1 May 2006

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

106

1 reference

Europe PubMed Central

24 November 2017

9

1 reference

Europe PubMed Central

24 November 2017

1908-1916

1 reference

Europe PubMed Central

24 November 2017

Gastrin: growth enhancing effects on human gastric and colonic tumour cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

21 January 2018

Growth responses of rat stomach cancer cells to gastro-entero-pancreatic hormones.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

7 January 2021

based on heuristic

inferred from DOI database lookup

Coexpression of gastrin and gastrin receptors (CCK-B and delta CCK-B) in gastrointestinal tumour cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of gastrin-induced proangiogenic effects in vivo in orthotopic U373 experimental human glioblastomas and in vitro in human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

7 January 2021

based on heuristic

inferred from DOI database lookup

Autocrine gastrins in colon cancer cells Up-regulate cytochrome c oxidase Vb and down-regulate efflux of cytochrome c and activation of caspase-3

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular mechanisms for the antiapoptotic action of gastrin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastrin activates nuclear factor kappaB (NFkappaB) through a protein kinase C dependent pathway involving NFkappaB inducing kinase, inhibitor kappaB (IkappaB) kinase, and tumour necrosis factor receptor associated factor 6 (TRAF6) in MKN-28 cells tr

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

7 January 2021

based on heuristic

inferred from DOI database lookup

Pre-clinical evaluation of the Gastrimmune immunogen alone and in combination with 5-fluorouracil/leucovorin in a rat colorectal cancer model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-gastrin antibodies raised by gastrimmune inhibit growth of the human colorectal tumour AP5.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

7 January 2021

based on heuristic

inferred from DOI database lookup

Necrosis and apoptosis in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

7 January 2021

based on heuristic

inferred from DOI database lookup

Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: A Phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II evaluation of low-dose continuous 5-fluorouracil and weekly cisplatin in advanced adenocarcinoma of the stomach. A Southwest Oncology Group study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21814

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21814

1 reference

Europe PubMed Central

24 November 2017

release_qpnvxdzu5bdbjh6ygstunpwpnu

1 reference

https://api.fatcat.wiki/v0/release/qpnvxdzu5bdbjh6ygstunpwpnu

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43567698&oldid=2101158370"